Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chemotherapy
Pharma
Jazz's almost-withdrawn lung cancer drug shows life
Jazz proposed two phase 3 trials to keep Zepzelca's accelerated approval a few years ago, and one of them has read out positively.
Angus Liu
Oct 15, 2024 10:15am
Coherus' Udenyca in short supply thanks to contractor flub
Sep 17, 2024 2:25pm
Sagent pulls docetaxel injections due to particulate concerns
May 30, 2024 11:22am
US shortage tally reaches all-time high, pharmacist group says
Apr 11, 2024 10:12am
Lawmakers launch probe into FDA's drug shortage oversight
Nov 6, 2023 9:32am
Merck's Keytruda mostly won out at ESMO, with one notable miss
Oct 24, 2023 9:05am
